Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes.
Wandall HH, Blixt O, Tarp MA, Pedersen JW, Bennett EP, Mandel U, Ragupathi G, Livingston PO, Hollingsworth MA, Taylor-Papadimitriou J, Burchell J, Clausen H.
Wandall HH, et al.
Cancer Res. 2010 Feb 15;70(4):1306-13. doi: 10.1158/0008-5472.CAN-09-2893. Epub 2010 Feb 2.
Cancer Res. 2010.
PMID: 20124478
Free PMC article.